| A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer (NCT04069026) | Bayer | 2019-08-15 |
| Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum (NCT03603366) | Bayer | 2019-08-14 |
| Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII) (NCT04015492) | Bayer | 2019-08-08 |
| Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested. (NCT04027192) | Bayer | 2019-07-31 |
| Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer (NCT04081831) | Bayer | 2019-07-31 |
| Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs (NCT03863990) | Bayer | 2019-07-15 |
| Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status (NCT04004195) | Bayer | 2019-07-10 |
| Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes (NCT03875469) | Bayer | 2019-06-21 |
| Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study (NCT03334838) | Bayer | 2019-06-10 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics, and Drug-drug Interaction of Multiple Oral Doses of BAY1830839 in Healthy Male Participants (NCT03965728) | Bayer | 2019-06-05 |
| A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies (NCT03926143) | Bayer | 2019-06-03 |
| Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners (NCT03965741) | Bayer | 2019-05-30 |
| A Trial to Study BAY1753011 in Patients With Congestive Heart Failure (NCT03901729) | Bayer | 2019-05-29 |
| A Study to Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants (NCT06125366) | Bayer | 2019-04-17 |
| Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU (NCT03904732) | Bayer | 2019-04-15 |
| Treatment Satisfaction With Ra-223 in Japan (NCT03315260) | Bayer | 2019-04-11 |
| A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed (NCT03890731) | Bayer | 2019-04-02 |
| Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo). (NCT03896984) | Bayer | 2019-03-18 |
| A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering (NCT03852563) | Bayer | 2019-03-18 |
| Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice (NCT03847181) | Bayer | 2019-02-28 |
| PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon (NCT03808142) | Bayer | 2019-02-20 |
| Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice (NCT03290794) | Bayer | 2019-02-14 |
| A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After a Peeling in the External Genital Area of Women (NCT03853512) | Bayer | 2019-02-12 |
| A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the Groin and Intimate Area (NCT03853525) | Bayer | 2019-02-11 |
| End-stage Renal Disease (ESRD) Pilot Study (NCT03787368) | Bayer | 2019-01-31 |
| A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering (NCT03853538) | Bayer | 2019-01-28 |
| Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina. (NCT03714308) | Bayer | 2019-01-28 |
| 4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness (NCT03841032) | Bayer | 2019-01-28 |
| Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment (NCT03644511) | Bayer | 2019-01-24 |
| Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects (NCT04511611) | Bayer | 2019-01-24 |
| This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (NCT03754660) | Bayer | 2019-01-21 |
| Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 15 mg in Japanese Healthy Male Adult Subjects (NCT04511637) | Bayer | 2019-01-21 |
| Study to Learn More About the Effect of Itraconazole (ITZ) Given Repeatedly by Mouth on the Way How the Study Drug BAY1902607 Given One Time by Mouth Acts in the Human Body of Healthy Male Participants (NCT03789890) | Bayer | 2019-01-08 |
| Rogaratinib (BAY1163877) in Chinese Patients (NCT03788603) | Bayer | 2019-01-07 |
| Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03724747) | Bayer | 2018-12-18 |
| Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina (NCT03784391) | Bayer | 2018-12-14 |
| A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein (NCT03773068) | Bayer | 2018-12-13 |
| A Study Run at Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also be Used to Assess Changes of Severity of HMB in Women With HMB Who Are Treated During 12 Months With a Chronic Hormonal Treatment (NCT03751800) | Bayer | 2018-12-12 |
| Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation (NCT03708133) | Bayer | 2018-12-05 |
| Multi-academic Center Study of Xofigo Patients (NCT03419442) | Bayer | 2018-12-03 |
| Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation (NCT03746301) | Bayer | 2018-12-03 |
| Study on Medical Records of Women Using an Intrauterine Device (IUD) to Analyze the Risks That the IUD Will be Expelled or Perforates the Womb in Relation to Breastfeeding, the Point in Time When the IUD Was Inserted After Childbirth and in Relation to Different Types of IUDs (NCT03754556) | Bayer | 2018-12-03 |
| Study to Find Out How Symptoms Severity Changes During the Standard Course of Treatment With the Cream Relief Pro and Suppositories Relief Pro (Active Ingredients Are Fluocortolone + Lidocaine) in Patients Suffering From Twisted and Bulging Veins in the Rectal Area (Acute Hemorrhoids) (NCT03757078) | Bayer | 2018-11-30 |
| Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose (NCT03602339) | Bayer | 2018-11-14 |
| Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid (NCT03746275) | Bayer | 2018-11-13 |
| Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle" (NCT03588299) | Bayer | 2018-11-07 |
| A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients. (NCT03715725) | Bayer | 2018-10-31 |
| EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK (NCT03743883) | Bayer | 2018-10-30 |
| Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (NCT03699176) | Bayer | 2018-10-27 |
| Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers. (NCT03704519) | Bayer | 2018-10-23 |
| An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors (NCT03735628) | Bayer | 2018-10-17 |
| Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid (NCT03622801) | Bayer | 2018-10-12 |
| Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied (NCT03639675) | Bayer | 2018-10-03 |
| In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control (NCT03441568) | Bayer | 2018-09-26 |
| Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation) (NCT03672383) | Bayer | 2018-09-17 |
| Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1. (NCT03666273) | Bayer | 2018-09-12 |
| Effect of Copanlisib on Metformin Pharmacokinetics and Pharmacodynamics (NCT03655301) | Bayer | 2018-09-11 |
| Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor (NCT03603678) | Bayer | 2018-08-13 |
| Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry (NCT03603275) | Bayer | 2018-08-06 |
| A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223 (NCT03563014) | Bayer | 2018-07-31 |
| Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC). (NCT03564938) | Bayer | 2018-07-30 |
| Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors (NCT03517956) | Bayer | 2018-07-25 |
| Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data (NCT03605810) | Bayer | 2018-07-15 |
| Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%) (NCT03599323) | Bayer | 2018-07-10 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis (NCT03573336) | Bayer | 2018-07-04 |
| EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan (NCT03579732) | Bayer | 2018-06-29 |
| A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale (NCT03570554) | Bayer | 2018-06-29 |
| BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics (NCT03540615) | Bayer | 2018-06-28 |
| Maintenance Treatment of Renal Anemia in Dialysis Subjects (NCT03543657) | Bayer | 2018-06-23 |
| A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components (NCT03562624) | Bayer | 2018-06-22 |
| Study of BAY1834942 in Patients With Solid Tumors (NCT03596372) | Bayer | 2018-06-19 |
| Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC (NCT03347292) | Bayer | 2018-06-18 |
| Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon (NCT03563937) | Bayer | 2018-06-15 |
| Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF (NCT03547583) | Bayer | 2018-06-15 |
| Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg (NCT03350295) | Bayer | 2018-06-14 |
| First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin (NCT03507452) | Bayer | 2018-06-13 |
| An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks (NCT03556787) | Bayer | 2018-06-04 |
| Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma (NCT03410693) | Bayer | 2018-05-31 |
| Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients (NCT03535168) | Bayer | 2018-05-29 |
| Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat (NCT03504982) | Bayer | 2018-05-17 |
| Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma (NCT03473756) | Bayer | 2018-05-15 |
| A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia (NCT03481946) | Bayer | 2018-05-10 |
| An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies (NCT03521895) | Bayer | 2018-05-01 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (NCT03458728) | Bayer | 2018-04-30 |
| A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects (NCT03517943) | Bayer | 2018-04-24 |
| A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects (NCT03517930) | Bayer | 2018-04-17 |
| A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis (NCT03493269) | Bayer | 2018-04-16 |
| An Evaluation of a Customized Insole to Provide Relief From Heel Pain Due to Plantar Fasciitis or General Heel Pain When Used in Footwear Over a Period of Four Weeks (NCT03507478) | Bayer | 2018-04-10 |
| REALIsM-HF Pilot Study (NCT03507439) | Bayer | 2018-04-06 |
| Rogaratinib (BAY1163877) Human Mass Balance Study (NCT03484585) | Bayer | 2018-04-06 |
| A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea (NCT03448536) | Bayer | 2018-04-05 |
| A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies (NCT03404726) | Bayer | 2018-03-29 |
| A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (NCT03470103) | Bayer | 2018-03-28 |
| BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food Effect (NCT03427788) | Bayer | 2018-03-21 |
| Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban) (NCT03455439) | Bayer | 2018-03-16 |
| Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients (NCT03349684) | Bayer | 2018-03-05 |
| Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases (NCT03474757) | Bayer | 2018-02-28 |
| Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD) (NCT03411941) | Bayer | 2018-02-28 |
| A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure (NCT03443843) | Bayer | 2018-02-21 |
| Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies (NCT03405337) | Bayer | 2018-02-14 |